- $48.08bn
- $65.48bn
- $28.43bn
Annual balance sheet for Medline, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Cash and Equivalents | |||
| Cash and Short Term Investments | 1,556 | 199 | 1,939 |
| Net Total Accounts Receivable | |||
| Net Total Receivables | 2,960 | 3,219 | 3,533 |
| Total Inventory | |||
| Total Other Current Assets | |||
| Total Current Assets | 8,809 | 8,272 | 10,679 |
| Gross Property, Plant And Equipment | |||
| Accumulated Depreciation | |||
| Net Property, Plant And Equipment | 4,797 | 4,979 | 5,210 |
| Net Goodwill | |||
| Net Intangible Assets | |||
| Other Long Term Assets | |||
| Total Assets | 36,122 | 35,978 | 38,484 |
| Accounts Payable | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Current Portion of Long Term Debt / Capital Leases | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 2,131 | 2,440 | 2,490 |
| Long Term Debt | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Minority Interest | |||
| Total Other Liabilities | |||
| Total Funded Status | |||
| Total Liabilities | 19,145 | 19,454 | 27,747 |
| Common Stock | |||
| Additional Paid In Capital | |||
| Retained Earnings (Accumulated Deficit) | |||
| Other Equity | |||
| Total Equity | 16,977 | 16,524 | 10,737 |
| Total Liabilities & Shareholders' Equity | 36,122 | 35,978 | 38,484 |
| Total Common Shares Outstanding |